Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Total revenue | 13.74%40.17M | 14.99%35.31M | 101.03%30.71M | 15.28M |
| Operating revenue | 13.74%40.17M | 14.99%35.31M | 101.03%30.71M | --15.28M |
| Cost of revenue | 1.43%1.55M | -23.39%1.52M | 6.34%1.99M | 1.87M |
| Gross profit | 14.29%38.62M | 17.65%33.79M | 114.24%28.72M | 13.41M |
| Operating expense | 10.75%28.27M | -23.80%25.53M | -19.07%33.5M | 41.4M |
| Selling and administrative expenses | 19.89%12.53M | -30.73%10.45M | -27.64%15.09M | --20.86M |
| -Selling and marketing expense | 45.22%5.14M | -32.45%3.54M | -59.16%5.24M | --12.84M |
| -General and administrative expense | 6.91%7.39M | -29.81%6.91M | 22.88%9.85M | --8.01M |
| Depreciation amortization depletion | 98.49%1.02M | 6.00%512.72K | -22.21%483.69K | --621.79K |
| -Depreciation and amortization | 98.49%1.02M | 6.00%512.72K | -22.21%483.69K | --621.79K |
| Provision for doubtful accounts | -11.37%9.04M | -27.96%10.2M | 74.58%14.16M | --8.11M |
| Other operating expenses | 30.28%5.68M | 15.68%4.36M | -68.09%3.77M | --11.81M |
| Operating profit | 25.25%10.35M | 272.61%8.26M | 82.91%-4.79M | -28M |
| Net non-operating interest income (expenses) | -15.36%-5.08M | -36.18%-4.4M | -91.44%-3.23M | -1.69M |
| Non-operating interest income | -72.32%7.91K | 107.11%28.59K | -60.21%13.81K | --34.7K |
| Non-operating interest expense | 11.25%4.91M | 38.28%4.41M | 94.13%3.19M | --1.64M |
| Total other finance cost | 739.35%180.82K | -62.78%21.54K | -28.35%57.88K | --80.78K |
| Other net income (expenses) | 1,274.36%109.66K | -99.42%7.98K | 154.05%1.38M | 544.73K |
| Special income (charges) | --1.45K | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --1.45K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 1,256.21%108.21K | -99.42%7.98K | 154.05%1.38M | --544.73K |
| Income before tax | 39.10%5.37M | 158.23%3.86M | 77.23%-6.64M | -29.14M |
| Income tax | -1.37M | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||
| Net income | 74.49%6.74M | 158.23%3.86M | 77.23%-6.64M | -29.14M |
| Net income continuous operations | 74.49%6.74M | 158.23%3.86M | 77.23%-6.64M | ---29.14M |
| Noncontrolling interests | ||||
| Net income attributable to the company | 74.49%6.74M | 158.23%3.86M | 77.23%-6.64M | -29.14M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | 74.49%6.74M | 158.23%3.86M | 77.23%-6.64M | -29.14M |
| Diluted earnings per share | 88.43%0.14 | 153.07%0.0743 | 83.33%-0.14 | -0.84 |
| Basic earnings per share | 74.97%0.13 | 153.07%0.0743 | 83.33%-0.14 | -0.84 |
| Dividend per share | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |